These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 604977)
21. Monitoring of drug concentrations in saliva: a non-invasive pharmacokinetic procedure. Ritschel WA; Tompson GA Methods Find Exp Clin Pharmacol; 1983 Oct; 5(8):511-25. PubMed ID: 6363838 [No Abstract] [Full Text] [Related]
22. Effects of liver congestion on hepatic drug metabolism in the rat. Knodell RG; Farleigh RM; Steele NM; Bond JH J Pharmacol Exp Ther; 1982 Apr; 221(1):52-7. PubMed ID: 7062291 [TBL] [Abstract][Full Text] [Related]
23. [Pediatric pharmacology. Practical ideas of kinetics and metabolism of drugs]. Royer RJ Arch Fr Pediatr; 1976 Apr; 33(4):401-7. PubMed ID: 952595 [TBL] [Abstract][Full Text] [Related]
24. [Metabolism of drugs in the liver and disease]. Sonne J; Døssing M; Loft S Ugeskr Laeger; 1988 Jan; 150(4):204-9. PubMed ID: 3376323 [No Abstract] [Full Text] [Related]
25. [Pharmacotherapy in the elderly]. Wessel K Fortschr Neurol Psychiatr; 2009 Feb; 77(2):110-9. PubMed ID: 19221975 [No Abstract] [Full Text] [Related]
26. Drug pharmacokinetics in cardiac and hepatic disease. Williams RL; Benet LZ Annu Rev Pharmacol Toxicol; 1980; 20():389-413. PubMed ID: 6992701 [No Abstract] [Full Text] [Related]
27. Drug disposition in liver disease. Fruncillo RJ Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640 [No Abstract] [Full Text] [Related]
28. [Pharmacokinetics as a basic pharmacological problem]. Dettli L Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():59-73. PubMed ID: 4906026 [No Abstract] [Full Text] [Related]
30. [Presystemic elimination and biological availability of drugs]. Klotz U Med Lab (Stuttg); 1981; 34(7-8):171-6. PubMed ID: 7311931 [No Abstract] [Full Text] [Related]
31. The influence of host factors on drug response. VII. Renal diseases. Vesell ES Ration Drug Ther; 1981 Nov; 15(11):1-9. PubMed ID: 7345476 [No Abstract] [Full Text] [Related]
32. [Dose adaptation of drugs for liver patients using a simple risk classification]. Zysset T; Bircher J Internist (Berl); 1983 Mar; 24(3):151-61. PubMed ID: 6347941 [No Abstract] [Full Text] [Related]
33. Pharmacokinetic changes in critical illness. Boucher BA; Wood GC; Swanson JM Crit Care Clin; 2006 Apr; 22(2):255-71, vi. PubMed ID: 16677999 [TBL] [Abstract][Full Text] [Related]
35. Drug disposition and liver disease. Wilkinson GR; Schenker S Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104 [No Abstract] [Full Text] [Related]
36. [Bioavailability and its significance in pharmacotherapy]. Wiela-Hojeńska A; Orzechowska-Juzwenko K Pol Merkur Lekarski; 2003 Jan; 14(79):89-93. PubMed ID: 12712840 [TBL] [Abstract][Full Text] [Related]
37. Factors influencing plasma drug concentrations. Luscombe DK J Int Med Res; 1977; 5(1 Suppl):82-97. PubMed ID: 863093 [TBL] [Abstract][Full Text] [Related]
38. [Influence of disease on the metabolism and effects of drugs in man]. Lavigne JG Union Med Can; 1980 Dec; 109(12):1718-22. PubMed ID: 7210314 [No Abstract] [Full Text] [Related]
39. [Drug therapy in impaired liver and kidney function]. Galeazzi RL Schweiz Med Wochenschr; 1983 May; 113(20):726-32. PubMed ID: 6879125 [TBL] [Abstract][Full Text] [Related]
40. The significance of drugs in breast milk. Pharmacokinetic considerations. Rivera-Calimlim L Clin Perinatol; 1987 Mar; 14(1):51-70. PubMed ID: 3549115 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]